SRZNW logo

Surrozen, Inc. Warrant


SRZNW: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).


Show SRZNW Financials

Consumer Interest
SEC Filings

Recent trades of SRZNW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by SRZNW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SRZNW in WallStreetBets Daily Discussion


Recent insights relating to SRZNW

CNBC Recommendations

Recent picks made for SRZNW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SRZNW

Corporate Flights

Flights by private jets registered to SRZNW